Citadel Advisors’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$457K Buy
9,700
+3,600
+59% +$178K ﹤0.01% 9515
2025
Q4
$287K Buy
+6,100
New +$283K ﹤0.01% 10242
2025
Q3
Sell
-6,900
Closed -$254K 14341
2025
Q2
$254K Sell
6,900
-1,700
-20% -$56.5K ﹤0.01% 10180
2025
Q1
$261K Sell
8,600
-51,700
-86% -$1.49M ﹤0.01% 9897
2024
Q4
$1.71M Sell
60,300
-6,600
-10% -$178K ﹤0.01% 5954
2024
Q3
$1.75M Buy
66,900
+65,900
+6,590% +$1.28M ﹤0.01% 5793
2024
Q2
$14.6K Sell
1,000
-200
-17% -$2.83K ﹤0.01% 12872
2024
Q1
$17.7K Buy
+1,200
New +$16.5K ﹤0.01% 13090

Other funds holding AHR

Citadel Advisors's AHR Position: Q1 2026 in Review

Citadel Advisors increased its American Healthcare REIT (AHR) stake by 340% in Q1 2026, buying an estimated $33.6M and bringing the position to 877,170 shares worth $41.4M. The position accounts for 0.01% of the portfolio, ranked #1541.

Citadel Advisors first reported a position in AHR in Q1 2024 and has held it in 8 quarters since. 518 funds tracked by Wall St. Rank hold AHR as of Q1 2026.

  • Citadel Advisors held 877,170 shares of American Healthcare REIT worth $41.4M as of Q1 2026.
  • Citadel Advisors bought 678,001 American Healthcare REIT shares in Q1 2026, an estimated $33.6M.
  • American Healthcare REIT made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1541 holding.
  • Citadel Advisors first reported a position in American Healthcare REIT in Q1 2024 and has held it in 8 quarters since.
  • 518 funds tracked by Wall St. Rank held American Healthcare REIT as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.